Capnat (Capecitabine) – Patient Guide (UK)

Capnat is a brand of capecitabine, an anticancer medicine used to treat certain cancers. This guide explains what Capnat is, how it works, how it is usually taken, and what to expect in terms of safety and drug interactions. It is written to be patient-friendly and focused on typical UK practical considerations.

1) Basic product information

2) What Capnat is used for (indications)

Capecitabine is used for several cancers, either alone or combined with other medicines. In the UK, the most common clinical uses include:

• Breast cancer: e.g., as part of combination treatment in certain stages and settings (such as metastatic or locally advanced disease, depending on the regimen).
• Colon cancer and rectal (colorectal) cancer: including treatment in some advanced settings and as adjuvant therapy after surgery for specific risk groups.
• Gastric (stomach) cancer: in combination regimens for advanced disease, where capecitabine is an option.

The exact plan depends on your diagnosis, stage, prior treatments, and overall health. Your oncology team will outline a specific regimen and schedule.

3) How Capnat works (mechanism of action)

Capecitabine is a prodrug—it is converted in the body into its active form, primarily within tumour tissues. It is designed to preferentially expose cancer cells to the active drug.

Key points:

• Capecitabine is converted to 5-fluorouracil (5-FU) through a sequence of enzymatic steps.
• The active drug disrupts DNA and RNA synthesis, which slows and prevents cancer cell growth.
• It mainly targets rapidly dividing cells, which is why side effects can affect tissues that renew quickly (such as the gut lining and skin).

4) Pharmacokinetics (how the body handles it)

Pharmacokinetics describes how the body absorbs, distributes, metabolises, and eliminates a medicine. For capecitabine:

• Absorption: Taken by mouth and absorbed through the gastrointestinal tract.
• Activation: After absorption, the drug is metabolised to intermediates and ultimately to 5-FU.
• Distribution: The active metabolites circulate and can act in both tumour and healthy tissues.
• Excretion: Metabolites are eliminated primarily via the kidneys (urine).

Because elimination depends partly on kidney function, dosing may need adjustment for people with renal impairment.

5) Typical dosing and timing

Capnat is taken as tablets. The dose is usually determined by:

• Body surface area (BSA) (calculated from height and weight),
• Your blood counts,
• Kidney function,
• How well you tolerate the medicine and any side effects.

Many schedules use a cycle approach. One common pattern is: 14 days of tablets followed by 7 days off (a 3-week cycle). However, other regimens exist, including different cycle lengths and combinations with other anticancer agents.

How to take Capnat tablets

• Swallow the tablets whole with water.
• Take within 30 minutes after a meal (see food section below).
• Do not take missed doses to “catch up” unless your clinical team has instructed you to do so.
• If you vomit shortly after taking a dose, contact your care team for advice (do not automatically repeat the dose).

Timing with meals (important)

Capecitabine is typically taken twice daily on treatment days. Many regimens schedule it as:

• Morning dose after breakfast (within 30 minutes)
• Evening dose after dinner (within 30 minutes)

Your regimen may specify a precise dose strength per day and day-by-day schedule. Always follow your specific plan.

6) Food interactions and what to eat

Food can affect how capecitabine is absorbed. For most patients:

• Take after meals—commonly within 30 minutes after food.
• Avoid taking on an empty stomach unless your clinician instructs otherwise.

General dietary support: If you experience nausea, mouth sores, or diarrhoea, smaller, frequent meals and hydration may help. Your oncology team or dietitian can advise on nutrition strategies during treatment.

7) Alcohol and medicine interactions

There is no single universal “safe” amount of alcohol during cancer treatment, but alcohol may increase the risk of:

• Dehydration (especially if diarrhoea occurs)
• Stomach irritation and nausea
• Medication stress on the body during active treatment

Practical advice: It is usually best to avoid alcohol or keep it to a minimum, especially during early cycles or if side effects occur. Ask your oncology team what is appropriate for you.

Important medicine interactions

Several drug interactions are clinically relevant. Always tell your healthcare team about all medicines you take, including: over-the-counter products, herbal supplements, and vitamins.

• Warfarin and other vitamin K antagonists: can increase the risk of bleeding. Close INR monitoring may be required.
• Phenytoin: may have altered levels; monitoring may be needed.
• Antacids containing aluminium or magnesium: may affect absorption in some cases.
• Allopurinol and other medications affecting uric acid metabolism: may require caution depending on your situation.
• Folinic acid (leucovorin) and other cancer medicines: can change effectiveness and toxicity when used in combination.
• Other medicines that affect kidney function or dehydration risk: may increase exposure and side effect risk.

If you need pain relief or anti-sickness medication, do not self-select products without checking compatibility.

8) Safety profile and side effects

Like all anticancer medicines, Capnat can cause side effects. Some are common and manageable; others are serious and require urgent medical attention. Your care team may adjust doses, delay cycles, or prescribe supportive treatments depending on side effects.

Common side effects

• Diarrhoea
• Nausea and sometimes vomiting
• Loss of appetite
• Fatigue (tiredness)
• Mouth sores (stomatitis)
• Skin changes
• Hand–foot syndrome: redness, swelling, pain, or peeling of the palms and soles
• Abdominal discomfort
• Constipation can also occur in some people

Serious side effects – seek urgent help

Contact your urgent care service or cancer team promptly if you develop any of the following:

• Severe diarrhoea, or diarrhoea that does not improve quickly
• Signs of dehydration: dizziness, very low urine output, extreme thirst
• Fever (often defined as a temperature ≥ 38°C) or chills, which may indicate infection
• Severe mouth ulcers preventing eating or drinking
• Severe hand–foot syndrome: blistering, ulceration, or intense pain
• Breathing difficulties, swelling of the face/throat, or severe rash (possible allergy)
• Unusual bleeding or bruising (especially if taking medicines like warfarin)

When dose adjustment may be considered

Dose reductions and treatment interruptions are common safety measures in chemotherapy. Your team will usually base decisions on:

• Severity and duration of diarrhoea or mouth inflammation
• Degree of hand–foot syndrome
• Blood test results (for example neutrophils and platelets)
• Kidney function and overall tolerance

9) Practical use tips (day-to-day guidance)

• Keep a treatment diary: record cycle dates, doses, side effects, and any supportive medicines used.
• Store tablets safely: keep out of sight and reach of children; follow the package storage instructions.
• Take at the same times each day on treatment days to help maintain consistency.
• Hand–foot prevention: avoid heat and friction on hands/feet (hot baths, tight shoes, vigorous exercise with pressure). Use moisturisers and protective measures if advised by your care team.
• Diarrhoea prevention: stay well hydrated; discuss early anti-diarrhoeal plans with your team. Early treatment matters.
• Mouth care: gentle oral hygiene, bland rinses, and prompt reporting of sores can help.
• Infection precautions: if you feel unwell or develop fever, seek advice promptly.

10) Dealing with common side effects

Diarrhoea

Diarrhoea can occur and may become severe. Because capecitabine can reduce the lining of the gut, symptoms should be treated early. Your oncology team may give you medicines to take at the start of diarrhoea.

• Drink small amounts frequently to maintain hydration.
• Avoid dehydration and seek medical advice if symptoms are worsening.
• Notify your team immediately if you cannot keep fluids down or if diarrhoea is severe.

Hand–foot syndrome

• Report symptoms early (redness, tingling, soreness).
• Use moisturisers and avoid friction and heat on affected areas.
• Do not apply irritant substances to broken skin; ask your team for specific recommendations.

Nausea and appetite changes

• Small, frequent meals often help.
• Let your team know early—anti-sickness medicines are available and can be adjusted.
• Maintain hydration even if appetite is low.

11) Alternative options

“Alternative options” depend on the type and stage of cancer, your previous treatments, and your individual health factors. If capecitabine is not suitable, oncology teams may consider other chemotherapy agents or treatment approaches, such as:

• Other oral fluoropyrimidines or regimens used in colorectal and gastric cancers
• Intravenous chemotherapy options (e.g., other fluorouracil-based regimens)
• Targeted therapies or immunotherapies where appropriate (depending on biomarkers)
• Radiotherapy and surgery in curative settings

Your specialist will weigh the benefits and risks of each approach with you.

12) UK market and legal context (high-level)

In the UK, anticancer medicines are regulated and distributed through established healthcare pathways. Availability can vary by formulation, strength, and supply conditions. Many anticancer medicines are supplied to patients via NHS services and oncology clinics, with some community pharmacy support depending on local arrangements.

For online pharmacy purchases, availability and eligibility rules differ. Always ensure you use an approved UK pharmacy and check that the product is supplied legally and in a suitable form for your needs.

If you are unsure whether a specific supply route is appropriate in your situation, ask your treating team or a pharmacist.

13) Recent guidance and monitoring (what to expect in practice)

Clinical practice continues to emphasise:

• Early recognition and prompt management of diarrhoea, infections, and hand–foot syndrome.
• Regular blood tests and kidney function monitoring during treatment cycles.
• Individualised dose modifications based on tolerance and side effect severity.
• Supportive care plans (hydration strategies, anti-diarrhoeal plans, mouth care) being discussed in advance.

Your oncology team will provide a specific safety plan, including when to call for help and which symptoms require urgent action.

14) Delivery, availability, and how to receive Capnat (UK)

Availability may depend on stock levels, tablet strength, and supply timelines. When ordering online in the UK:

• Confirm the strength and pack size match your treatment plan.
• Check the delivery timeframe shown at checkout.
• Ensure someone can receive the parcel if delivery requires a signature.
• Store tablets correctly as soon as you receive them.

If you experience delays, do not improvise doses. Contact your pharmacy or treatment team for guidance.

15) FAQ about Capnat (capecitabine)

Can I take Capnat with food?

Yes. Capecitabine is usually taken after meals (commonly within 30 minutes after food). This helps ensure appropriate absorption. Follow your specific regimen instructions.

What should I do if I miss a dose?

If you miss a dose, follow the guidance provided by your clinical team. In general, you should not take extra doses to compensate unless instructed. Contact your oncology team or pharmacist for advice about your specific situation and dosing schedule.

How long does a treatment cycle last?

It depends on the regimen. A common schedule is 14 days on treatment followed by 7 days off, making a 3-week cycle. Other schedules exist, especially in combination therapies.

What is hand–foot syndrome and when should I report it?

Hand–foot syndrome is a side effect that can cause redness, swelling, pain, tingling, or peeling on the palms and soles. You should report early symptoms to your care team promptly, especially if they affect daily activities or cause blistering.

Is it safe to drive while taking Capnat?

Capecitabine can cause tiredness and sometimes dizziness. If you feel unwell or unusually drowsy, avoid driving. Follow advice from your healthcare team and ensure you feel safe and alert.

Can I take paracetamol for pain or fever?

Many people can take paracetamol, but it depends on your overall health and other medicines. Confirm with your pharmacist or clinician, particularly if you have liver disease or are taking additional medications.

What if I get diarrhoea—should I wait?

No. Diarrhoea on capecitabine can become serious. Notify your oncology team early and follow any anti-diarrhoeal plan they provide. Seek urgent help if diarrhoea is severe, persistent, or you show signs of dehydration.

Does Capnat affect fertility or pregnancy?

Capecitabine can affect rapidly dividing cells and may carry risks to a developing baby. People who can become pregnant or father children should discuss contraception and pregnancy planning with their healthcare team before starting treatment.

Are vaccinations safe during treatment?

Some vaccinations may be safe, while others (particularly live vaccines) may not be recommended during chemotherapy. Ask your oncology team for an up-to-date vaccination plan.

Can I use creams or moisturisers for hand–foot syndrome?

Moisturisers are often encouraged, but specific product choices can depend on your skin symptoms. Ask your care team or pharmacist what to use and what to avoid, especially if your skin becomes blistered or broken.

16) When to contact a healthcare professional immediately

Contact your oncology team or seek urgent medical help if you have:

• Fever (commonly ≥ 38°C) or signs of infection
• Severe diarrhoea or dehydration
• Severe mouth sores preventing eating/drinking
• Severe hand–foot syndrome (blisters, ulcers, severe pain)
• Unusual bleeding or bruising
• Allergic reaction symptoms (swelling, breathing difficulty, widespread rash)

If you are ever unsure, it is better to get advice early—prompt management can help prevent complications.